De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
- PMID: 33299146
- DOI: 10.1038/s41436-020-01020-w
De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
Erratum in
-
Correction to: De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy.Genet Med. 2021 Apr;23(4):796. doi: 10.1038/s41436-020-01090-w. Genet Med. 2021. PMID: 33686260 No abstract available.
Abstract
Purpose: This study aims to provide a comprehensive description of the phenotypic and genotypic spectrum of SNAP25 developmental and epileptic encephalopathy (SNAP25-DEE) by reviewing newly identified and previously reported individuals.
Methods: Individuals harboring heterozygous missense or loss-of-function variants in SNAP25 were assembled through collaboration with international colleagues, matchmaking platforms, and literature review. For each individual, detailed phenotyping, classification, and structural modeling of the identified variant were performed.
Results: The cohort comprises 23 individuals with pathogenic or likely pathogenic de novo variants in SNAP25. Intellectual disability and early-onset epilepsy were identified as the core symptoms of SNAP25-DEE, with recurrent findings of movement disorders, cerebral visual impairment, and brain atrophy. Structural modeling for all variants predicted possible functional defects concerning SNAP25 or impaired interaction with other components of the SNARE complex.
Conclusion: We provide a comprehensive description of SNAP25-DEE with intellectual disability and early-onset epilepsy mostly occurring before the age of two years. These core symptoms and additional recurrent phenotypes show an overlap to genes encoding other components or associated proteins of the SNARE complex such as STX1B, STXBP1, or VAMP2. Thus, these findings advance the concept of a group of neurodevelopmental disorders that may be termed "SNAREopathies."
Similar articles
-
Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy.Eur J Hum Genet. 2023 Mar;31(3):345-352. doi: 10.1038/s41431-022-01269-6. Epub 2022 Dec 23. Eur J Hum Genet. 2023. PMID: 36564538 Free PMC article.
-
Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.Am J Med Genet A. 2020 Apr;182(4):713-720. doi: 10.1002/ajmg.a.61483. Epub 2020 Jan 11. Am J Med Genet A. 2020. PMID: 31926053
-
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.Am J Hum Genet. 2017 Nov 2;101(5):664-685. doi: 10.1016/j.ajhg.2017.09.008. Am J Hum Genet. 2017. PMID: 29100083 Free PMC article.
-
STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.Neurology. 2016 Mar 8;86(10):954-62. doi: 10.1212/WNL.0000000000002457. Epub 2016 Feb 10. Neurology. 2016. PMID: 26865513 Review.
-
De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review.Seizure. 2023 Oct;111:138-146. doi: 10.1016/j.seizure.2023.08.009. Epub 2023 Aug 18. Seizure. 2023. PMID: 37633153 Review.
Cited by
-
Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.Front Pediatr. 2023 Oct 9;11:1266376. doi: 10.3389/fped.2023.1266376. eCollection 2023. Front Pediatr. 2023. PMID: 37900685 Free PMC article.
-
Genetic disorders of neurotransmitter release machinery.Front Synaptic Neurosci. 2023 Mar 31;15:1148957. doi: 10.3389/fnsyn.2023.1148957. eCollection 2023. Front Synaptic Neurosci. 2023. PMID: 37066095 Free PMC article. Review.
-
A recurrent de novo splice site variant involving DNM1 exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanism.Am J Hum Genet. 2022 Dec 1;109(12):2253-2269. doi: 10.1016/j.ajhg.2022.11.002. Epub 2022 Nov 21. Am J Hum Genet. 2022. PMID: 36413998 Free PMC article.
-
Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder.Genet Med. 2022 Apr;24(4):880-893. doi: 10.1016/j.gim.2021.12.002. Epub 2022 Jan 29. Genet Med. 2022. PMID: 35101335 Free PMC article.
-
Epileptic Phenotypes Associated With SNAREs and Related Synaptic Vesicle Exocytosis Machinery.Front Neurol. 2022 Jan 13;12:806506. doi: 10.3389/fneur.2021.806506. eCollection 2021. Front Neurol. 2022. PMID: 35095745 Free PMC article. Review.
References
-
- Rizo, J. & Xu, J. The synaptic vesicle release machinery. Annu. Rev. Biophys. 44, 339–367, https://doi.org/10.1146/annurev-biophys-060414-034057 (2015). - DOI - PubMed
-
- Jahn, R. & Fasshauer, D. Molecular machines governing exocytosis of synaptic vesicles. Nature. 490, 201–207, https://doi.org/10.1038/nature11320 (2012). - DOI - PubMed - PMC
-
- Ramakrishnan, N. A., Drescher, M. J. & Drescher, D. G. The SNARE complex in neuronal and sensory cells. Mol. Cell. Neurosci. 50, 58–69, https://doi.org/10.1016/j.mcn.2012.03.009 (2012). - DOI - PubMed - PMC
-
- Hepp, R. & Langley, K. SNAREs during development. Cell Tissue Res. 305, 247–253, https://doi.org/10.1007/s004410100359 (2001). - DOI - PubMed
-
- Han, J., Pluhackova, K. & Böckmann, R. A. The multifaceted role of SNARE proteins in membrane fusion. Front. Physiol. 8, 5, https://doi.org/10.3389/fphys.2017.00005 (2017). - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
